Roundview Capital LLC increased its stake in Medtronic PLC (NYSE:MDT) by 12.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,901 shares of the medical technology company’s stock after acquiring an additional 785 shares during the period. Roundview Capital LLC’s holdings in Medtronic PLC were worth $612,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in MDT. Vanguard Group Inc. lifted its stake in Medtronic PLC by 2.4% in the second quarter. Vanguard Group Inc. now owns 104,776,036 shares of the medical technology company’s stock worth $9,298,872,000 after purchasing an additional 2,454,380 shares during the last quarter. BlackRock Inc. lifted its stake in Medtronic PLC by 2.8% in the second quarter. BlackRock Inc. now owns 89,512,229 shares of the medical technology company’s stock worth $7,944,210,000 after purchasing an additional 2,476,853 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its stake in Medtronic PLC by 3.0% in the first quarter. Massachusetts Financial Services Co. MA now owns 58,646,070 shares of the medical technology company’s stock worth $4,724,526,000 after purchasing an additional 1,729,715 shares during the last quarter. Lazard Asset Management LLC lifted its stake in Medtronic PLC by 43.8% in the second quarter. Lazard Asset Management LLC now owns 19,669,866 shares of the medical technology company’s stock worth $1,745,699,000 after purchasing an additional 5,991,094 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in Medtronic PLC by 7.3% in the first quarter. Geode Capital Management LLC now owns 13,308,812 shares of the medical technology company’s stock worth $1,070,622,000 after purchasing an additional 906,581 shares during the last quarter. Institutional investors own 81.37% of the company’s stock.

Shares of Medtronic PLC (NYSE MDT) opened at $79.33 on Monday. The firm has a market cap of $107,459.70, a PE ratio of 16.92, a price-to-earnings-growth ratio of 2.19 and a beta of 1.00. The company has a quick ratio of 1.40, a current ratio of 1.64 and a debt-to-equity ratio of 0.51. Medtronic PLC has a fifty-two week low of $69.35 and a fifty-two week high of $89.72.

Medtronic PLC (NYSE:MDT) last announced its quarterly earnings data on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.04. The business had revenue of $7.39 billion for the quarter, compared to analysts’ expectations of $7.44 billion. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.03 earnings per share. equities analysts expect that Medtronic PLC will post 4.66 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 20th. Shareholders of record on Friday, September 29th were issued a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date was Thursday, September 28th. Medtronic PLC’s dividend payout ratio (DPR) is presently 61.95%.

Several analysts have weighed in on MDT shares. Needham & Company LLC reissued a “buy” rating and issued a $94.00 price target on shares of Medtronic PLC in a research note on Thursday. BidaskClub downgraded shares of Medtronic PLC from a “hold” rating to a “sell” rating in a research note on Saturday, August 26th. Zacks Investment Research downgraded shares of Medtronic PLC from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Royal Bank Of Canada lowered their price objective on shares of Medtronic PLC from $90.00 to $85.00 and set an “outperform” rating for the company in a research note on Monday, October 9th. Finally, SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $96.00 price objective on shares of Medtronic PLC in a research note on Friday, November 3rd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have issued a buy rating to the company’s stock. Medtronic PLC currently has a consensus rating of “Hold” and a consensus target price of $87.88.

In other news, CEO Omar Ishrak sold 140,407 shares of the stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $81.63, for a total transaction of $11,461,423.41. Following the sale, the chief executive officer now owns 668,503 shares in the company, valued at $54,569,899.89. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Bryan C. Hanson sold 16,000 shares of the stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $78.03, for a total transaction of $1,248,480.00. The disclosure for this sale can be found here. 0.31% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/roundview-capital-llc-increases-position-in-medtronic-plc-mdt/1699482.html.

Medtronic PLC Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.